10 CFR 35.15: Exemptions regarding Type A specific licenses of broad scope.
Where this section sits in the code
- Title 10—Energy
- CHAPTER I—NUCLEAR REGULATORY COMMISSION
- PART 35—MEDICAL USE OF BYPRODUCT MATERIAL
- Subpart A—General Information
A licensee possessing a Type A specific license of broad scope for medical use, issued under Part 33 of this chapter, is exempt from—
(a) The provisions of § 35.12(d) regarding the need to file an amendment to the license for medical use of byproduct material, as described in § 35.1000;
(b) The provisions of § 35.13(b);
(c) The provisions of § 35.13(f) regarding additions to or changes in the areas of use at the addresses identified in the application or on the license;
(d) The provisions of § 35.14(a);
(e) The provisions of § 35.14(b)(1) for an authorized user, an authorized nuclear pharmacist, an authorized medical physicist, or an ophthalmic physicist;
(f) The provisions of § 35.14(b)(5).
(g) The provisions of § 35.49(a).
Collected 2026-08-27T02:24:09Z. Source file · JSON